Generation and analysis of HBcAg-specific CTL clones in a patient with acute hepatitis B郑纪山, 何长伦, 王寿明, 张益红, 唐雨德, 戴宇东200-202,206
Purified HBV promoting Smad3 expression in human hepatic stellate cell line LX-2 cells吴晓宁, 白启轩, 刘天会, 李佳, 尤红, 贾继东203-206
Mutations possibly associated with tenofovir disoproxil fumarate resistance in 1 740 patients with chronic hepatitis B梁兆玲, 刘妍, 苏何玲, 孟玉华, 罗莉蓉, 王静, 戴久增, 姚增涛, 徐东平207-210
Efficacy and response prediction in the treatment of HBeAg-positive chronic hepatitis B with interferon alpha-2b徐京杭, 于岩岩, 斯崇文, 陈新月, 韩忠厚, 陈勇, 张文瑾, 陈宇萍, 李雪迎211-215
Therapeutic effect of 48 weeks of telbivudine on HBeAg-positive chronic hepatitis B陈仕晓, 胡晓中, 朱帆, 万彬, 刘萍216-218
Correlation between the efficacy of adefovir dipivoxil on HBeAg-negative patients with chronic hepatitis B and HBV genotypes胡章勇, 杨军, 许颖, 夏绍碧, 刘福元219-221
Therapeutic effect of different durations of IFN-α treatment for HBeAg-positive chronic hepatitis B and 3 years of follow-up李旭红, 赖江琼, 李奕鑫, 王崇国222-224